Search for grants with us!
Grants you might be eligible for
Fiscal Year 2025 Solar Module and Solar Hardware (SMASH) Incubator
DE-FOA-0003460
Programme: Renewable Energy Research and Development
Grant Overview
Eligibility Criteria
Funding
Up to 4000000.00 USD
Eligible Participants
Deadline
May 30, 2025, 4 a.m.
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
PAR-25-090
Programme: NIH Grants
GRANT OVERVIEW
ELIGIBILITY CRITERIA
Up to 225000.00 USD
June 10, 2027, 10 p.m.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
PAR-25-352
Up to None USD
Oct. 25, 2027, 10 p.m.
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
PAR-25-332
Programme: Extramural Research Programs in the Neurosciences and Neurological Disorders
Nov. 5, 2027, 10 p.m.
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer's Disease and Related Dementias (R01 Clinical Trial Not Allowed)
PAR-25-374
Up to 1000000.00 USD
May 7, 2028, 10 p.m.
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
PAR-25-355
Up to 275000.00 USD
Jan. 7, 2027, 10 p.m.
Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
PAR-25-048
Sept. 7, 2025, 10 p.m.
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
PA-25-301
Jan. 7, 2028, 10 p.m.
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
PAR-25-354
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
PAR-25-327
Oct. 8, 2027, 10 p.m.
Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed)
RFA-DA-25-074
Programme: National Institutes of Health (NIH)
Aug. 13, 2025, 10 p.m.
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
PAR-25-277
Programme: NIDDK Research Grants
Oct. 15, 2027, 10 p.m.
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
PAR-25-032
Up to 450000.00 USD
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
PAR-24-280
Programme: NIH Research Project Grant
Up to 250000.00 USD
Nov. 2, 2026, 10 p.m.
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
PAR-24-329
May 7, 2027, 10 p.m.
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
RFA-TR-25-002
Programme: National Center for Advancing Translational Sciences
June 2, 2026, 10 p.m.
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
PAR-25-346
Up to 200000.00 USD
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
PA-25-169
Up to 400000.00 USD
Jan. 7, 2026, 10 p.m.
NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
RFA-DC-25-002
Programme: NIDCD Research Grants
Up to 500000.00 USD
Oct. 12, 2027, 10 p.m.
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
PAR-25-357
Oct. 16, 2027, 9 p.m.
789 results. Page 2 of 40.